ENLIVEN THERAPEUTICS

We are developing kinase inhibitors that enhance efficacy through better selectivity and combinability, combat resistance, address brain metastases, and improve safety and patient convenience... We are a biopharmaceutical company focused on the discovery and development of small molecule kinase inhibitors to help patients with cancer live longer and better.

Also known as: Enliven Therapeutics, Inc.

Primary location: Boulder United States